H. Ulrich-Pur

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Werner Scheithauer, B. Schüll, H. Ulrich-Pur et al. · Annals of Oncology · 2002 · 187 citations · Full text

Oncology, Pancreatic Cancer, Gastrointestinal Oncology +6

Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancer

M. Penz, Gabriela Kornek, Markus Raderer et al. · Annals of Oncology · 2001 · 176 citations

Urology, Surgical Oncology, Phase Ii Trial +9

Irinotecan plus raltitrexed vs raltitrexed alone in patients with gemcitabine-pretreated advanced pancreatic adenocarcinoma

H. Ulrich-Pur, Markus Raderer, Gabriela Kornek et al. · British Journal of Cancer · 2003 · 117 citations · Full text

Surgical Oncology, Urology, Pancreatic Cancer +14

CD44‐positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2)

Axel Schulenburg, P Cech, Irene Herbacek et al. · The Journal of Pathology · 2007 · 81 citations

Tumor Biology, Oncology, Medicine +13

Comparison of Mucosal Pressures Induced by Cuffs of Different Airway Devices

H. Ulrich-Pur, F. Hrska, Peter Krafft et al. · Anesthesiology · 2006 · 62 citations · Full text